XML 17 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net (loss) income $ (4,051) $ 3,706
Adjustments to reconcile net (loss) income to net cash used for operating activities:    
Depreciation and amortization 4,246 4,270
Amortization of inventory step-up 7,028 0
Accretion of investment discount (69) (194)
Provision for accounts receivable allowances 1,298 2,553
Deferred tax (benefit) provision (362) 799
Share-based compensation expense 803 688
Gain on bargain purchase 0 (376)
(Gain) loss on sale of assets (14) 43
Changes in assets and liabilities:    
Accounts receivable (47,443) (48,987)
Inventory (8,436) (19,815)
Prepaid expenses and other assets (3,516) (48)
Accounts payable 11,865 12,514
Other accrued liabilities and long-term obligations 4,489 2,821
Total adjustments (30,111) (45,732)
Net cash used for operating activities (34,162) (42,026)
Cash flows from investing activities:    
Maturities of investment securities 20,000 60,000
Purchase of a business 0 (1,125)
Purchase of property, plant and equipment (2,021) (2,831)
Purchase of company owned life insurance policy (750) 0
Purchase of intangibles 0 (100)
Proceeds from sale of fixed assets 14 311
Net cash provided by investing activities 17,243 56,255
Cash flows from financing activities:    
Payments on long-term debt (109) 0
Dividends paid (3,644) (3,634)
Exercise of stock options, net of tax withholdings 37 (32)
Payments for tax withholding on net restricted stock settlements 0 (527)
Tax effect on stock awards 0 278
Net cash used for financing activities (3,716) (3,915)
Effect of exchange rate changes on cash 156 0
Net (decrease) increase in cash and cash equivalents (20,479) 10,314
Cash and cash equivalents at beginning of period 47,693 19,927
Cash and cash equivalents at end of period $ 27,214 $ 30,241